Bristol-Myers and Celgene CEOs talk acquisition deal
7,295
Published 2019-01-07
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favoarite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Find CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Google+: cnb.cx/PlusCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC
#CNBC
All Comments (6)
-
Bristol-Myers Squibb has been working decades for the people. See this adjuvant relevancy first before profit.
-
Great endeavour and research. Hope to see those 5 meds soon. Screw the stock if it was the right time to buy go for it. Just keep doing your job for our healthcare. 😎
-
He was craping on the deal the day it was announced.. Look at its video on TheStreet Chanel.
-
Bad news for everyone. Monopoly.
-
imagine being so wildly greedy that u seek more and more and profit special bonuses off of people's worst pain... wouldn't wish cancer on anyone but wish he could live one day in those peoples' shoes that actually need this 719$ per pill drug. Greed knows no bounds.
